BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 19205412)

  • 1. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages.
    Montserrat E; Viñolas N; Reverter JC; Rozman C
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):359-61. PubMed ID: 3222145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of serum albumin in chronic lymphocytic leukemia.
    Levis A; Ficara F; Marmont F; De Crescenzo A; Resegotti L
    Haematologica; 1991; 76(2):113-9. PubMed ID: 1937168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia.
    Orfao A; Ciudad J; González M; San Miguel JF; García AR; López-Berges MC; Ramos F; Del Cañizo MC; Ríos A; Sanz M
    Leukemia; 1992 Jan; 6(1):47-51. PubMed ID: 1736013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal.
    Melo JV; Catovsky D; Galton DA
    Blood Cells; 1987; 12(2):339-53. PubMed ID: 3476167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic relevancy of histomorphological bone marrow findings in chronic lymphocytic leukemia (CLL)].
    Wutke K; Scheibner K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):218-30. PubMed ID: 6194055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-chronic lymphocytic leukemia. Disease progression in 150 untreated stage A and B patients as predicted by bone marrow pattern.
    Pangalis GA; Boussiotis VA; Kittas C
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):373-5. PubMed ID: 3222147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of expression of IgG Fc receptors in patients with chronic B-cell lymphoid leukemia].
    Schranz V
    Orv Hetil; 1991 Oct; 132(43):2359-60, 2363-6. PubMed ID: 1834972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and clinical staging in chronic lymphocytic leukemia.
    Rai KR; Han T
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):447-56. PubMed ID: 2182601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytometric study of lymph node lymphocytes in patients with chronic lymphocytic leukemia and their prognostic significance].
    Kolarović J
    Med Pregl; 1991; 44(11-12):521-3. PubMed ID: 1821457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic lymphatic leukemia. I. Clinico-biological features and survival analysis. Study of 187 patients].
    Jarque I; Sanz G; Gomis F; Martínez G; de la Rubia J; López F; Sanz MA
    Sangre (Barc); 1991 Aug; 36(4):277-84. PubMed ID: 1776106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.
    Juliusson G; Oscier DG; Fitchett M; Ross FM; Stockdill G; Mackie MJ; Parker AC; Castoldi GL; Guneo A; Knuutila S; Elonen E; Gahrton G
    N Engl J Med; 1990 Sep; 323(11):720-4. PubMed ID: 2201915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic lymphatic leukemia. II. Analysis of prognostic factors and development of survival predicting models. Study of 187 patients].
    Jarque I; Sanz G; Gomis F; Martínez J; Martín G; de la Rubia J; López F; Sanz MA
    Sangre (Barc); 1991 Aug; 36(4):285-94. PubMed ID: 1776107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T gamma lymphocytosis and T cell chronic leukemias.
    Berliner N
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):473-87. PubMed ID: 2182603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parameters significant for the prognosis of chronic myeloid leukemia in the chronic phase].
    Maras J; Ribicić I; Maras-Simunić M; Skare L
    Acta Med Iugosl; 1990; 44(4):389-97. PubMed ID: 2091442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance.
    Viñolas N; Reverter JC; Urbano-Ispizua A; Montserrat E; Rozman C
    Blood Cells; 1987; 12(2):457-70. PubMed ID: 3620708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of T lymphocyte subpopulations in malignant lymphoproliferative diseases].
    Milosević D; Marinković M; Suvajdzić N; Spuzić I
    Glas Srp Akad Nauka Med; 1991; (41):105-11. PubMed ID: 1916436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolymphocytic leukemia.
    Stone RM
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):457-71. PubMed ID: 2182602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node biopsy in chronic lymphocytic leukemia: prognostic significance of histopathological, morphometry and immunohistological findings.
    Raphael M; Debré P; Guigui B; Binet JL
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):379-83. PubMed ID: 3265507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of 10 patients with chronic lymphoid leukemia].
    Fukuda T; Makino S; Tamura K; Suzumiya J; Kimura N; Ohshima K; Kikuchi M; Sagawa K
    Rinsho Ketsueki; 1992 Aug; 33(8):1017-24. PubMed ID: 1404856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.